Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-18-032803)

Filing Details

Accession Number:: 0001209191-18-032803
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-05-23 21:52:37
Reporting Period:: 2018-05-21

Accepted Time:: 2018-05-23 21:52:37
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1340652	Chemocentryx Inc.	CCXI	Pharmaceutical Preparations (2834)	943254365

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1422995	J. Markus Cappel	C/O Chemocentryx, Inc. 850 Maude Avenue Mountain View CA 94043	Chief Bus. Officer & Treasurer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-05-21	2,709	$6.00	26,535	No	4	M	Direct
Common Stock	Disposition	2018-05-21	2,709	$13.00	23,826	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to buy)	Disposition	2018-05-21	2,709	$0.00	2,709	$6.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
58,125	2009-07-28	2019-07-29	No	4	M	Direct

Footnotes

Shares sold are associated with stock options that will expire in September 2019.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
As of May 21, 2018, and prior to this transaction, the exercised options were fully vested.
Not applicable.